Spirit AeroSystems Names Mindy McPheeters as General Counsel
WICHITA, Kan., March 11, 2021 /PRNewswire/ -- Spirit AeroSystems [NYSE: SPR] announced today that Mindy McPheeters has been named as Senior Vice President, General Counsel and Corporate Secretary, effective immediately. McPheeters will be a member of Spirit's Executive Leadership Team and report directly to Tom Gentile, President and Chief Executive Officer for Spirit AeroSystems.
McPheeters had been serving as Interim General Counsel for Spirit AeroSystems prior to her permanent placement in this role. Previously, McPheeters was Vice President, Deputy General Counsel, for Spirit AeroSystems.
"Mindy has gained an understanding of the many facets of our business and our industry during her tenure with the company," said Gentile. "I look forward to her contributions as a member of our Executive Leadership Team as we continue to transform Spirit into a more diversified company."
During her six years at Spirit, McPheeters has also held positions overseeing various aspects of Legal, including Litigation, Commercial, Employment and Compliance. Prior to joining Spirit, McPheeters served as In-house Counsel for Delta Dental of Kansas.
On the web: www.spiritaero.com On Twitter: @SpiritAero
About Spirit AeroSystems Inc.Spirit AeroSystems is one of the world's largest manufacturers of aerostructures for commercial airplanes, defense platforms, and business/regional jets. With expertise in aluminum and advanced composite manufacturing solutions, the company's core products include fuselages, integrated wings and wing components, pylons, and nacelles. Also, Spirit serves the aftermarket for commercial and business/regional jets. Headquartered in Wichita, Kansas, Spirit has facilities in the U.S., U.K., France, Malaysia and Morocco. More information is available at www.spiritaero.com.
View original content:http://www.prnewswire.com/news-releases/spirit-aerosystems-names-mindy-mcpheeters-as-general-counsel-301246111.html
SOURCE Spirit AeroSystems Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Johnson & Johnson reports 75% tumor response rate in advanced prostate cancer with JNJ-6143, a first-in-class RIPTAC™ molecule
- ST Engineering iDirect and MBSat Partner to Build Next-Generation Sovereign Connectivity Services Across Oman and the Middle East
- Zhejiang Wenda Pharma Announces Positive Results from Phase II Trial of Oral BET Inhibitor NHWD-870 HCl at the 2026 ESMO Annual Meeting
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share